PIK3CA and neoplasm: Despite the negative results of the PIK3CA mutations and the PI3K signaling pathway, in the analysis of cell composition using bulk tissue RNA-seq data, we found a stronger infiltration of CD8+ naïve T cells to the tumor microenvironment among responders vs. non-responders to CRT, as well as among aspirin vs. non-aspirin users.